• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对功能良好的社区居住老年人进行观察性队列研究,以评估他们在12个月内的肌肉减少症状态、休闲体育活动和生活质量。

Observational cohort study of highly functioning community-dwelling older adults to assess their sarcopenic status, leisure physical activity, and quality of life over 12-months.

作者信息

Juby A G, Davis C M J, Minimaana S, Mager D R

机构信息

Department of Medicine, Division of Geriatrics, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.

Faculty of Kinesiology, University of Alberta, Edmonton, Alberta, Canada.

出版信息

Heliyon. 2023 Sep 16;9(9):e20078. doi: 10.1016/j.heliyon.2023.e20078. eCollection 2023 Sep.

DOI:10.1016/j.heliyon.2023.e20078
PMID:37809471
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10559810/
Abstract

BACKGROUND

The prevalence of sarcopenia varies depending on the cohort evaluated, and the diagnostic criteria used. Older adults with sarcopenia report lower quality of life than their non-sarcopenic peers. Leisure physical activity is reported to have a variable effect on sarcopenic status. Most studies to date, have been done in "vulnerable" populations, with fewer done on independent community-dwelling older adults. None have been done in an Alberta, Canada population.

OBJECTIVES

To prospectively evaluate the sarcopenic status of independent community-dwelling older Albertan adults; whether this changed over 12-months; and any association with self-reported leisure activity or quality of life.

METHODS

Independent community-dwelling older adults were invited to participate in a 12-month observational study. Assessments were done at baseline, 6 and 12-months for physical function (TUG, SPPB, gait speed, Tinetti, grip strength), muscle mass (DXA, arm and calf circumference), body fat (skinfold, DXA), reported daily exercise (aerobic, resistance), quality of life (EQ5D), and laboratory parameters. European Working Group on Sarcopenia in Older People (EWGSOP) definitions of sarcopenic status were used.

RESULTS

All 50 participants (11 male), were independent of all basic activities of daily living at baseline, and most instrumental activities (some needed assistance with driving or finances). They had an average age of 75.8 (67-90) years, with average MMSE and MoCA cognitive scores of 28.1/30 (20-30) and 24.8/30 (14-30) respectively. Eight participants dropped out prior to their first DXA test. Of the remaining 42, 17 participants (5 male) fulfilled the EWGSOP revised criteria for probable, pre-sarcopenia, or sarcopenia, giving a rate of baseline total sarcopenia of 40.5% in this community-dwelling sample. The majority were pre-sarcopenic (28.6%), and sarcopenia was present only in 7.1%. The total sarcopenia group had a lower BMI (25.6 ± 5.1 versus 29 ± 5, p = 0.01), less body fat by skinfold measurement (36.4 ± 6.5 versus 39.3 ± 8.1, p = 0.01) and lower mid-calf (35.6 ± 3.2 versus 37.6 ± 3.4, p = 0.04) and mid-arm (29.1 ± 2.5 versus 31.9 ± 3.5, p = 0.02) circumferences when compared to their non-sarcopenic peers. After 12-months, 39 participants remained in the study. Of these, the sarcopenic status of 7 improved, 10 declined, with the remaining 56% not changing. There were no statistically significant differences in baseline laboratory parameters between the groups, including 25(OH)D status. But, of the status decliners, 40% had suboptimal 25(OH)D at baseline. Self-reported leisure activity (both total time and frequency) was not associated with sarcopenic status at 12-months. EuroQol -5D was not associated with sarcopenic status.

CONCLUSIONS

The rate of sarcopenia was 7.1%, but the total rate of pre, probable and sarcopenia in this highly functioning, community-dwelling older adult cohort was 40.5%. In the majority (75%), there was either no change, or an improvement, in their sarcopenic status over 12-months. There was no association identified with self-reported leisure activity or quality of life in this cohort.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5420/10559810/52324d95ba99/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5420/10559810/4c05c2328da8/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5420/10559810/52324d95ba99/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5420/10559810/4c05c2328da8/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5420/10559810/52324d95ba99/gr2.jpg
摘要

背景

肌肉减少症的患病率因所评估的队列以及所使用的诊断标准而异。与非肌肉减少症的同龄人相比,患有肌肉减少症的老年人报告生活质量较低。据报道,休闲体育活动对肌肉减少症状态有不同的影响。迄今为止,大多数研究是在“脆弱”人群中进行的,而针对独立居住在社区的老年人的研究较少。在加拿大艾伯塔省人群中尚未开展此类研究。

目的

前瞻性评估独立居住在社区的艾伯塔省老年成年人的肌肉减少症状态;该状态在12个月内是否发生变化;以及与自我报告的休闲活动或生活质量的任何关联。

方法

邀请独立居住在社区的老年成年人参与一项为期12个月的观察性研究。在基线、6个月和12个月时进行评估,内容包括身体功能(定时起立行走试验、简短体能状况量表、步速、Tinetti量表、握力)、肌肉量(双能X线吸收法、上臂和小腿围)、体脂(皮褶厚度、双能X线吸收法)、报告的日常锻炼(有氧运动、抗阻运动)、生活质量(EQ-5D量表)以及实验室参数。采用欧洲老年人肌肉减少症工作组(EWGSOP)对肌肉减少症状态的定义。

结果

所有50名参与者(11名男性)在基线时均能独立完成所有基本日常生活活动,并且大多数能完成工具性日常生活活动(部分人在驾驶或理财方面需要协助)。他们的平均年龄为75.8(67 - 90)岁,简易精神状态检查表(MMSE)和蒙特利尔认知评估量表(MoCA)的平均认知得分分别为28.1/30(20 - 30)和24.8/3(14 - 30)。8名参与者在首次双能X线吸收法测试前退出。在其余42名参与者中,17名参与者(5名男性)符合EWGSOP修订的可能、疑似或确诊肌肉减少症的标准,在这个社区居住样本中,基线时总体肌肉减少症的发生率为40.5%。大多数为疑似肌肉减少症(28.6%),确诊肌肉减少症仅占7.1%。与非肌肉减少症的同龄人相比,总体肌肉减少症组的体重指数较低(25.6±5.1对29±5,p = 0.01),通过皮褶厚度测量的体脂较少(36.4±6.5对39.3±8.1,p = 0.01),小腿中部(35.6±3.2对37.6±3.4,p = 0.04)和上臂中部(29.1±2.5对31.9±3.5,p = 0.02)周长较小。12个月后,39名参与者仍留在研究中。其中,7名参与者的肌肉减少症状态有所改善,10名有所下降,其余56%未发生变化。两组之间的基线实验室参数,包括25(OH)D状态,无统计学显著差异。但是,在状态下降者中,40%在基线时25(OH)D水平欠佳。自我报告的休闲活动(总时长和频率)与12个月时的肌肉减少症状态无关。欧洲五维度健康量表(EuroQol - 5D)与肌肉减少症状态无关。

结论

肌肉减少症的发生率为7.1%,但在这个功能良好、居住在社区的老年成年人队列中,疑似和确诊肌肉减少症的总发生率为40.5%。在大多数人(75%)中,其肌肉减少症状态在12个月内没有变化或有所改善。在这个队列中,未发现与自我报告的休闲活动或生活质量之间存在关联。

相似文献

1
Observational cohort study of highly functioning community-dwelling older adults to assess their sarcopenic status, leisure physical activity, and quality of life over 12-months.对功能良好的社区居住老年人进行观察性队列研究,以评估他们在12个月内的肌肉减少症状态、休闲体育活动和生活质量。
Heliyon. 2023 Sep 16;9(9):e20078. doi: 10.1016/j.heliyon.2023.e20078. eCollection 2023 Sep.
2
Quality of life and physical components linked to sarcopenia: The SarcoPhAge study.与肌肉减少症相关的生活质量和身体组成部分:肌肉减少症衰老研究
Exp Gerontol. 2015 Sep;69:103-10. doi: 10.1016/j.exger.2015.05.003. Epub 2015 May 13.
3
Nutritional status, body composition, and quality of life in community-dwelling sarcopenic and non-sarcopenic older adults: A case-control study.社区居住的肌少症和非肌少症老年人的营养状况、身体成分和生活质量:一项病例对照研究。
Clin Nutr. 2017 Feb;36(1):267-274. doi: 10.1016/j.clnu.2015.11.013. Epub 2015 Nov 27.
4
Prevalence of Sarcopenia in Community-Dwelling Chilean Elders According to an Adapted Version of the European Working Group on Sarcopenia in Older People (EWGSOP) Criteria.根据老年人肌少症欧洲工作组(EWGSOP)标准的改编版本,智利社区居住老年人的肌少症患病率
J Frailty Aging. 2017;6(1):12-17. doi: 10.14283/jfa.2016.117.
5
Prevalence of sarcopenic obesity in Germany using established definitions: Baseline data of the FORMOsA study.采用既定定义的德国肌少症肥胖症患病率:FORMOSA研究的基线数据。
Osteoporos Int. 2016 Jan;27(1):275-81. doi: 10.1007/s00198-015-3303-y. Epub 2015 Aug 29.
6
Diagnostic differences and agreement between the original and revised European Working Group (EWGSOP) consensus definition for sarcopenia in community-dwelling older adults with type 2 diabetes mellitus.社区居住的 2 型糖尿病老年人群中肌少症的原始和修订的欧洲工作组(EWGSOP)共识定义之间的诊断差异和一致性。
Arch Gerontol Geriatr. 2020 Jul-Aug;89:104081. doi: 10.1016/j.archger.2020.104081. Epub 2020 Apr 21.
7
Prevalence of sarcopenia in community-dwelling older people in the UK using the European Working Group on Sarcopenia in Older People (EWGSOP) definition: findings from the Hertfordshire Cohort Study (HCS).使用欧洲老年人肌少症工作组(EWGSOP)定义评估英国社区居住老年人肌少症的流行率:赫特福德郡队列研究(HCS)的结果。
Age Ageing. 2013 May;42(3):378-84. doi: 10.1093/ageing/afs197. Epub 2013 Feb 5.
8
Cut-off points to identify sarcopenia according to European Working Group on Sarcopenia in Older People (EWGSOP) definition.根据老年肌少症欧洲工作组(EWGSOP)定义确定肌少症的切点。
Clin Nutr. 2016 Dec;35(6):1557-1563. doi: 10.1016/j.clnu.2016.02.002. Epub 2016 Feb 11.
9
Sarcopenia prevalence and functional outcomes in older men with obesity: Comparing the use of the EWGSOP2 sarcopenia versus ESPEN-EASO sarcopenic obesity consensus definitions.肥胖老年男性的肌肉减少症患病率和功能结局:比较使用 EWGSOP2 肌肉减少症与 ESPEN-EASO 肌肉减少性肥胖共识定义。
Clin Nutr. 2023 Sep;42(9):1610-1618. doi: 10.1016/j.clnu.2023.07.014. Epub 2023 Jul 17.
10
Bioimpedance analysis and physical functioning as mortality indicators among older sarcopenic people.生物阻抗分析和身体机能作为老年肌少症人群的死亡指标。
Exp Gerontol. 2019 Jul 15;122:42-46. doi: 10.1016/j.exger.2019.04.012. Epub 2019 Apr 24.

本文引用的文献

1
Epidemiology of sarcopenia: Prevalence, risk factors, and consequences.肌少症的流行病学:患病率、风险因素和后果。
Metabolism. 2023 Jul;144:155533. doi: 10.1016/j.metabol.2023.155533. Epub 2023 Mar 11.
2
A cross-sectional study about the relationship between physical activity and sarcopenia in Taiwanese older adults.一项关于台湾老年人身体活动与肌肉减少症之间关系的横断面研究。
Sci Rep. 2021 Jun 1;11(1):11488. doi: 10.1038/s41598-021-90869-1.
3
Physical exercise and prevention of falls. Effects of a Pilates training method compared with a general physical activity program: A randomized controlled trial.
身体锻炼与防跌倒。与一般体育活动方案相比普拉提训练方法的效果:一项随机对照试验。
Medicine (Baltimore). 2021 Apr 2;100(13):e25289. doi: 10.1097/MD.0000000000025289.
4
Prevalence of sarcopenic obesity and sarcopenic overweight in the general population: The lifelines cohort study.一般人群中肌少症性肥胖和肌少症性超重的流行情况:生命纵向研究。
Clin Nutr. 2021 Jun;40(6):4422-4429. doi: 10.1016/j.clnu.2021.01.005. Epub 2021 Jan 11.
5
Sex Differences in Adaptations in Muscle Strength and Size Following Resistance Training in Older Adults: A Systematic Review and Meta-analysis.老年人抗阻训练后肌肉力量和大小适应性的性别差异:系统评价和荟萃分析。
Sports Med. 2021 Mar;51(3):503-517. doi: 10.1007/s40279-020-01388-4.
6
Sarcopenia Prevalence Using Different Definitions in Older Community-Dwelling Canadians.肌少症在加拿大老年社区居民中的流行情况:使用不同定义的结果。
J Nutr Health Aging. 2020;24(7):783-790. doi: 10.1007/s12603-020-1427-z.
7
Exercise as a treatment for sarcopenia: an umbrella review of systematic review evidence.运动作为肌少症的一种治疗方法:系统综述证据的伞式评价。
Physiotherapy. 2020 Jun;107:189-201. doi: 10.1016/j.physio.2019.08.005. Epub 2019 Aug 9.
8
Current knowledge and practice of Australian and New Zealand health-care professionals in sarcopenia diagnosis and treatment: Time to move forward!澳大利亚和新西兰医护人员在肌少症诊断和治疗方面的现有知识和实践:是时候向前迈进了!
Australas J Ageing. 2020 Jun;39(2):e185-e193. doi: 10.1111/ajag.12730. Epub 2019 Oct 15.
9
Sarcopenia: new definitions, same limitations.肌肉减少症:新定义,旧局限。
Age Ageing. 2019 Sep 1;48(5):613-614. doi: 10.1093/ageing/afz087.
10
New Prediction Equations to Estimate Appendicular Skeletal Muscle Mass Using Calf Circumference: Results From NHANES 1999-2006.利用小腿围度估算四肢骨骼肌质量的新预测方程:NHANES 1999-2006 研究结果。
JPEN J Parenter Enteral Nutr. 2019 Nov;43(8):998-1007. doi: 10.1002/jpen.1605. Epub 2019 May 12.